Sanguinarine Attenuates Lipopolysaccharide-induced Inflammation and Apoptosis by Inhibiting the TLR4/NF-κB Pathway in H9c2 Cardiomyocytes
Authors:
- 30 April 2018
- journal article
- research article
- Published by Springer Nature in Current Medical Science
- Vol. 38 (2) , 204-211
Abstract
The inflammatory response is involved in the pathogenesis of the most common types of heart disease. Sanguinarine (SAN) has various pharmacological properties such as anti-inflammatory, antioxidant, antibacterial, antitumor, and immune-enhancing properties. However, few studies have investigated the effects of SAN on lipopolysaccharide (LPS)-induced inflammatory and apoptotic responses in H9c2 cardiomyocytes. Therefore, in this study, H9c2 cells were co-treated with SAN and LPS, and the mRNA levels of pro-inflammation markers and the apoptosis rate were measured to clarify the effect of SAN on cardiac inflammation. The underlying mechanism was further investigated by detecting the activation of Toll-like receptor (TLR)4/nuclear factor-κB (NF-κB) signaling pathways. As a result, increased mRNA expression of interleukin (IL)-1β, IL-6, and TNFα induced by LPS was attenuated after SAN treatment; LPS-induced apoptosis of H9c2 cardiomyocytes and cleaved-caspase 8, 9, 3 were all significantly reduced by SAN. Further experiments showed that the beneficial effect of SAN on blocking the inflammation and apoptosis of H9c2 cardiomyocytes induced by LPS was associated with suppression of the TLR4/NF-κB signaling pathway. It was suggested that SAN suppressed the LPS-induced inflammation and apoptosis of H9c2 cardiomyocytes, which may be mediated by inhibition of the TLR4/NF-κB signaling pathway. Thus, SAN may be a feasible therapy to treat sepsis patients with cardiac dysfunction.Keywords
This publication has 22 references indexed in Scilit:
- Sanguinarine Inhibits Vascular Endothelial Growth Factor Release by Generation of Reactive Oxygen Species in MCF-7 Human Mammary Adenocarcinoma CellsBioMed Research International, 2013
- Attenuation of cardiac dysfunction by HSPA12B in endotoxin-induced sepsis in mice through a PI3K-dependent mechanismCardiovascular Research, 2010
- Role of nuclear factor κB in cardiovascular health and diseaseClinical Science, 2010
- LPS/TLR4 signal transduction pathwayCytokine, 2008
- Sepsis and the HeartCirculation, 2007
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Sanguinarine (Pseudochelerythrine) Is a Potent Inhibitor of NF-κB Activation, IκBα Phosphorylation, and DegradationJournal of Biological Chemistry, 1997
- Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.Journal of Clinical Investigation, 1995
- Chelerythrine is a potent and specific inhibitor of protein kinase CBiochemical and Biophysical Research Communications, 1990
- Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"Nature, 1990